Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Callaghan

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|March 20, 1998
Olanzapine: interaction study with imipramineJ T Callaghan, B J Cerimele, K J Kassahun, et al.
Clinical Pharmacology and Therapeutics|December 13, 2012
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosingM S Hershfield, J T Callaghan, W Tassaneeyakul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Disposition in humans of racemic picenadol, an opioid analgesicP M Franz, S L Anliker, J T Callaghan, et al.
Pharmaceutical Research|January 6, 2001
Confidence interval criteria for assessment of dose proportionalityB P Smith, F R Vandenhende, K A DeSante, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1997
Disposition and biotransformation of the antipsychotic agent olanzapine in humansK Kassahun, E Mattiuz, E Nyhart, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics|August 8, 2014
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosingK E Caudle, A E Rettie, M Whirl-Carrillo, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
A pharmacokinetic profile of nizatidine in manJ T Callaghan, R F Bergstrom, A Rubin, et al.
The American Review of Respiratory Disease|November 1, 1989
Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmaticsE Israel, E F Juniper, J T Callaghan, et al.
Journal of Cardiovascular Pharmacology|June 20, 2007
The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rateMichael A Derby, Lu Zhang, Jill C Chappell, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|March 20, 1998
Olanzapine: interaction study with imipramineJ T Callaghan, B J Cerimele, K J Kassahun, et al.
Clinical Pharmacology and Therapeutics|December 13, 2012
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosingM S Hershfield, J T Callaghan, W Tassaneeyakul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Disposition in humans of racemic picenadol, an opioid analgesicP M Franz, S L Anliker, J T Callaghan, et al.
Pharmaceutical Research|January 6, 2001
Confidence interval criteria for assessment of dose proportionalityB P Smith, F R Vandenhende, K A DeSante, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1997
Disposition and biotransformation of the antipsychotic agent olanzapine in humansK Kassahun, E Mattiuz, E Nyhart, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics|August 8, 2014
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosingK E Caudle, A E Rettie, M Whirl-Carrillo, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
A pharmacokinetic profile of nizatidine in manJ T Callaghan, R F Bergstrom, A Rubin, et al.
The American Review of Respiratory Disease|November 1, 1989
Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmaticsE Israel, E F Juniper, J T Callaghan, et al.
Journal of Cardiovascular Pharmacology|June 20, 2007
The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rateMichael A Derby, Lu Zhang, Jill C Chappell, et al.
Pageof 4